MAÜ GCRIS Standart veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Investigation of nasal Staphylococcus aureus carriage by real-time PCR in patients receiving hemodialysis treatment

dc.authoridhttps://orcid.org/0000-0002-7855-5343
dc.contributor.authorCetik Yildiz, Songul
dc.contributor.authorDemir, Cemil
dc.date.accessioned2023-12-21T13:59:17Z
dc.date.available2023-12-21T13:59:17Z
dc.date.issued2023
dc.departmentMAÜ, Meslek Yüksekokulları, Sağlık Hizmetleri Meslek Yüksekokulu, Tıbbi Hizmetler ve Teknikler Bölümüen_US
dc.description.abstractABSTRACT Objectives: Staphylococcus aureus, coagulase-negative staphylococci (CoNS), and methicillin-resistant S. aureus (MRSA), which are significant nosocomial pathogens, have become a growing global problem because their carriage and diseases have become resistant to many antibiotics. This study aimed to investigate and determine the rate of MRSA carriage among patients receiving hemodialysis treatment using molecular methods. Methods: In the 254 hemodialysis patients, the nasal carriage rates, susceptibility and resistance to S. aureus, CoNS and MRSA were examined using culture and real-time PCR methods. Nasal samples from hemodialysis patients were examined using real-time PCR. Microscopic examination was performed using the Gram staining method, and S. aureus was identified using catalase and coagulase. The strains were then tested for antibiotic susceptibility. Staphylococci was isolated from 231 of the 254 patients. Results: S. aureus carriage was detected in 50 patients, MRSA in 16, methicillin-susceptible S. aureus (MSSA) in 33, CoNS in 66, methicillin-resistant CoNS (MR-CoNS) in 38, and methicillin-susceptible CoNS (MSCoNS) in 28. S. aureus and MRSA strains exhibited 100% susceptibility to nitrofurantoin, and vancomycin. MSSA strains showed the highest susceptibility to chloramphenicol, clindamycin (84.8%), and co-trimoxazole (36.4%). CoNS showed 100% susceptibility to vancomycin, and 16.7% susceptibility to ampicillin. Vancomycin was found to be the most effective antibiotic against S. aureus, CoNS, and MRSA pathogens identified in patients undergoing hemodialysis, whereas penicillin resistance was found. Conclusions: It can be concluded that one of the most effective ways to prevent the formation of antibiotic resistant strains is the hygiene of the hospital and hospital staff. Real-time PCR is very important for analyzing with high sensitivity.en_US
dc.description.provenanceSubmitted by Songül Çetik Yıldız (songulcetik@artuklu.edu.tr) on 2023-12-18T19:25:55Z No. of bitstreams: 1 EurpRes_2023.pdf: 304028 bytes, checksum: adfd86e556a8932312e4790484018d48 (MD5)en
dc.description.provenanceApproved for entry into archive by Cumali Keskin (cumalikeskin@artuklu.edu.tr) on 2023-12-21T13:59:17Z (GMT) No. of bitstreams: 1 EurpRes_2023.pdf: 304028 bytes, checksum: adfd86e556a8932312e4790484018d48 (MD5)en
dc.description.provenanceMade available in DSpace on 2023-12-21T13:59:17Z (GMT). No. of bitstreams: 1 EurpRes_2023.pdf: 304028 bytes, checksum: adfd86e556a8932312e4790484018d48 (MD5) Previous issue date: 2023en
dc.identifier.trdizinid1158529
dc.identifier.urihttps://hdl.handle.net/20.500.12514/5124
dc.institutionauthorCetik Yildiz, Songul
dc.language.isoenen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectStaphylococcus aureus, nasal carriage, antibiotic resistant, infection, real-time PCRen_US
dc.titleInvestigation of nasal Staphylococcus aureus carriage by real-time PCR in patients receiving hemodialysis treatmenten_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
EurpRes_2023.pdf
Size:
296.9 KB
Format:
Adobe Portable Document Format
Description:
Songül Çetik Yıldız , Cemil Demir. Investigation of nasal Staphylococcus aureus carriage by real-time PCR in patients receiving hemodialysis treatment. The European Research Journal 2023;9(2):277-284

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.44 KB
Format:
Item-specific license agreed upon to submission
Description: